Kachadourian Remy, Menzeleev Ramil, Agha Bushra, Bocckino Steve B, Day Brian J
Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206, USA
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 5;767(1):61-7. doi: 10.1016/s0378-4347(01)00531-x.
Recent studies have revealed potent pharmacological activities of manganese-containing cationic porphyrins. An analytical method employing high-performance liquid chromatography with spectrophotometric and electrochemical detection (HPLC-UV/EC) suitable for in vivo applications is described for a series of manganese(III) cationic porphyrins with good separation and resolution. In particular, this method resolved the four atropisomers of manganese(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin (MnTE-2-PyP5+ or AEOL-10113), verified by mass spectrometry. Electrochemical and spectrophotometric methods of detection were compared using manganese(III) meso-tetrakis(1,3-diethylimidazolium-2-yl)porphyrin (MnTDE-2-ImP5+ or AEOL-10150), the lead catalytic antioxidant of this series. Both methods of detection were quantitative, but electrochemical detection, although less specific for in vivo applications, appears to be considerably more sensitive than spectrophotometric detection.
最近的研究揭示了含锰阳离子卟啉具有强大的药理活性。本文描述了一种采用高效液相色谱结合分光光度法和电化学检测(HPLC-UV/EC)的分析方法,该方法适用于体内应用,用于一系列具有良好分离度和分辨率的锰(III)阳离子卟啉。特别地,该方法分离出了锰(III)中-四(N-乙基吡啶-2-基)卟啉(MnTE-2-PyP5+或AEOL-10113)的四种阻转异构体,并通过质谱进行了验证。使用该系列的铅催化抗氧化剂锰(III)中-四(1,3-二乙基咪唑-2-基)卟啉(MnTDE-2-ImP5+或AEOL-10150)对电化学检测方法和分光光度检测方法进行了比较。两种检测方法都是定量的,但电化学检测虽然对体内应用的特异性较低,但其灵敏度似乎比分光光度检测高得多。